This is a genetic condition that causes tumors to grow on nerves. These tumors can grow anywhere in the body, but often affect the nerves in the brain and spine. It's usually diagnosed in childhood or early adulthood. People with this condition need regular check-ups to monitor for any new tumors.
Every report comes from a Lived member, sent anonymously.
Have you had Neurosurgery for Neurofibromatosis 2?
Neurofibromatosis 2 (NF2) is a rare genetic condition that causes noncancerous tumors to grow along nerves in the brain, spinal cord and body. Its hallmark is a vestibular schwannoma (also called an acoustic neuroma) on the hearing and balance nerve of each ear. As these tumors grow, they press on the nerve, so the usual first symptoms are gradual hearing loss, ringing in the ears (tinnitus) and unsteadiness. Most people develop tumors on both sides, and many eventually lose most or all of their hearing. Other tumors are common too. Meningiomas grow from the membranes covering the brain and spinal cord, and schwannomas can form on other nerves or in the skin. Ependymomas grow inside the spinal cord and often cause no symptoms. Depending on where they grow, tumors can affect facial movement, swallowing, vision or strength and feeling in the limbs. Many people also have a particular type of cataract (clouding of the lens) from childhood that usually does not affect sight. Symptoms most often begin in the teens or twenties, though they can start at any age. In 2022 experts renamed the condition NF2-related schwannomatosis. Despite the similar old name, it is a separate condition from neurofibromatosis type 1 (NF1), which is far more common and causes different features.
NF2 is caused by a change in the NF2 gene, which normally makes a protein called merlin that keeps nerve-supporting cells from multiplying out of control. Nothing a person or their parents did causes it, and there are no known lifestyle triggers. About half of people inherit the gene change from a parent; in the rest it arises new. Someone who carries the change in every cell has a 50% chance of passing it to each child. In many people whose NF2 arose new, the change happened during early development and is present in only some cells, called mosaic NF2. Mosaic NF2 often affects one side or one region of the body more than others, can still be serious, and carries a lower chance of being passed on. Genetic counseling helps work out which situation applies.
Diagnosis usually starts with hearing loss, tinnitus or balance problems, especially in a young person or on both sides. A hearing test shows the pattern of loss, and an MRI (magnetic resonance imaging) scan of the brain and spine shows schwannomas, meningiomas and spinal tumors, even small ones that cause no symptoms yet. Tumors on both hearing and balance nerves are enough to make the diagnosis. Without that, doctors look at a combination of features: a tumor on one hearing nerve, multiple meningiomas, other NF2-type tumors, a parent with NF2, specific eye findings seen by an eye specialist, and genetic testing of blood or saliva. Because a mosaic gene change can be missed in blood, testing two separate tumors removed during surgery can confirm the diagnosis when the blood test is negative. Once a family's NF2 gene change is known, children and other relatives can be offered genetic testing and counseling.
There is currently no cure for NF2, and no medicine is approved by the US Food and Drug Administration (FDA) specifically for its tumors. Care aims to keep hearing, nerve function and quality of life for as long as possible, and it works best through a specialist NF2 team that sees the whole picture. Many tumors grow slowly or not at all, so a common approach is watchful monitoring with regular MRI scans and hearing tests, treating a tumor only when it grows or causes problems. Surgery can remove tumors that press on the brainstem or spinal cord, but operating near these nerves can damage hearing, facial movement or other functions, so its timing involves real trade-offs. Stereotactic radiosurgery, a focused single high dose of radiation, can stop many vestibular schwannomas from growing, though useful hearing is kept in fewer than half of treated ears. Specialists use radiation more cautiously in NF2 than for single tumors because of a possible small risk of later turning a tumor cancerous, a particular concern for younger people. Bevacizumab (Avastin), a cancer medicine given by intravenous infusion that blocks a signal tumors use to grow blood vessels, is used off label for growing vestibular schwannomas, meaning it is approved for certain cancers and specialists prescribe it for NF2 based on study results. In small studies it often slowed tumor growth and stabilized hearing, sometimes improving it, but not everyone responds. It commonly raises blood pressure and can cause protein in the urine, so both are checked during treatment, and tumors may regrow quickly if it is stopped. It can harm a developing pregnancy and may affect periods and fertility, so anyone who could become pregnant should discuss contraception (needed during treatment and for 6 months afterward) and family plans before starting. It also slows wound healing, so it has to be paused around surgery. Other targeted drugs are being studied in clinical trials. For hearing, hearing aids help while some natural hearing remains. A cochlear implant can work for some people whose hearing nerve is still intact and working, though results vary. An auditory brainstem implant, which stimulates the brainstem directly when the hearing nerve has been lost, is another option offered at a limited number of specialist centers. Eye care, physical therapy and treatment for pain, headaches or seizures address other effects.
NF2 varies a great deal, even within the same family. Some people have few tumors that grow slowly over decades; others, often those whose symptoms begin in childhood, have many tumors and a faster course. The type of gene change and whether it is mosaic also influence how severe it tends to be. NF2 is lifelong, and follow-up is part of everyday life: at least yearly visits to a specialist clinic, regular brain and spine MRI scans, hearing tests and eye checks, with closer monitoring when tumors are growing. Treatment decisions often come in stages, weighing when to act on one tumor against the effect on hearing or nerves. Hearing loss is the change most people plan around. Learning lip reading or sign language and setting up captioning and other communication tools while hearing remains makes the transition easier. Balance problems, facial weakness and vision changes can affect driving, work and daily activities, and support from audiologists, therapists and NF2 patient organizations can help. Life expectancy is shorter on average than in the general population, but it has improved with care at specialist centers and more careful timing of surgery and radiation.
Arrange an evaluation for hearing loss, ringing or balance problems in one or both ears in a young person, or if a parent, brother or sister has NF2. If you have NF2, contact your specialist team promptly, rather than waiting for the next scheduled visit, about a sudden drop in hearing or vision, new facial weakness, choking or trouble swallowing, new numbness or weakness in the arms or legs, or headaches with vomiting or blurred vision. These can mean a tumor is pressing on the brain, spinal cord or a nerve, or that fluid is building up around the brain. If you are taking bevacizumab, report home blood pressure readings above the target your prescriber set. Severe headache with vomiting together with drowsiness, confusion or difficulty waking, or choking with trouble breathing, needs emergency care (call 911). These can be signs of sudden fluid buildup in the brain or a tumor pressing on the brainstem.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Neurofibromatosis 2 is like, what's helped you, or ask the community a question.